Economic evidence is increasingly being used for informing health policies. However, the underlining principles of health economic analyses are not always fully understood by non-health economists, and inappropriate types of analyses, as well as inconsistent methodologies, may be being used for info

The number of published health economic analyses, especially economic evaluations, has rapidly expanded globally since the 1990s, and costs are an essential component of such studies. Cost is a general term that refers to the value of the resources/inputs used to produce a good or service. However,

Pritaporn Kingkaew1,*, PitsaphunWerayingyong1, San San Aye2, Nilar Tin3, Alaka Singh4, Phone Myint2 and Yot Teerawattananon1 1Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand, 2Department of Health Planning and 3Department of He

11-3-103-2559local authority,primary school,school health services,นักเรียน,บริการอนามัยโรงเรียน,องค์กรปกครองส่วนท้องถิ่น,โรงเรียน

Highlights Economic evidence (cost-effectiveness information) can be used to inform policy-making process in supporting the movement towards universal health coverage. Published literature has focused on methods to set a cost-effectiveness threshold (CET) which can be used to guide the cost-eff

The objectives of this study are to identify resources used for providing tetravalent dengue vaccine to prevent dengue infection in the Thai health care settingestimate the budget impact of dengue vaccination program nationwide and to conduct economic evaluation of providing tetravalent dengue vaccine program compared with no vaccination program. T

ในประเทศไทย มะเร็งปากมดลูกเป็นสาเหตุการเสียชีวิตที่พบได้มากเป็นอันดับ 2 ในสตรีรองจากมะเร็งเต้านม สาเหตุหลักของโรคมะเร็งป